Fact CheckerSign in

NCT04661878Completed

Piloting a Smartphone App to Improve Treatment Adherence Among South African Adolescents Living With HIV

Source: ClinicalTrials.gov · Last updated 13 Jun 2025

Brief summary (registry, in English)

The overall goal of this pilot randomized-controlled trial (RCT) is to pilot MASI (MAsakhane Siphucule Impilo Yethu; Xhosa for "Let's empower each other and improve our health"), an ART adherence-supporting smartphone app with 50 adolescents and young adults living with HIV to assess its feasibility and acceptability and to explore preliminary effects on ART adherence and social support.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
4 Dec 2020
Start date
21 Jun 2022
Primary completion date
15 Mar 2024
Lead sponsor
Duke University
Diseases
HIV
NCT number
NCT04661878

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 21 Jun 2022 to the primary completion date, 15 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Failure to meet any of the inclusion criteria

Other

  • Child dissent despite parent, legal guardian, caregiver informed consent

Who the study is looking for

  • Age \>= 15 years and \<= 21 years
  • Knows HIV status (Screened adolescents who do not know their HIV status will receive information on free voluntary HIV counseling and testing services)
  • Living with HIV
  • Has been prescribed medication to treat HIV
  • Not attending school for learners with special needs (e.g., School of Skills)
  • Has not repeated a grade in school more than once
  • Has a smartphone that can download apps
  • Feels comfortable using an app with content in English
  • No plan to move outside of Cape Town in the next six months
  • Has not previously participated in the MASI app testing phase of our study
  • Able to successfully install the MASI app on their smartphone

Age in the registry: 15 years to 21 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Cape Town
Coordinator of this site? Confirm its status
Cape TownSouth AfricaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.